Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Lazarus, A.
1987.
Dr. Lazarus Replies.
The Canadian Journal of Psychiatry,
Vol. 32,
Issue. 4,
p.
332.
Adityanjee
1987.
Role of electroconvulsive therapy in neuroleptic malignant syndrome (NMS).
Acta Psychiatrica Scandinavica,
Vol. 76,
Issue. 5,
p.
603.
Schou, M.
1988.
Vol. 12,
Issue. ,
p.
26.
Adityanjec
Singh, Suarn
Singh, Gurnam
and
Ong, Susan
1988.
Spectrum Concept of Neuroleptic Malignant Syndrome.
British Journal of Psychiatry,
Vol. 153,
Issue. 1,
p.
107.
Ebadi, M.
Pfeiffer, R.F.
and
Murrin, L.C.
1990.
Pathogenesis and treatment of neuroleptic malignant syndrome.
General Pharmacology: The Vascular System,
Vol. 21,
Issue. 4,
p.
367.
Amore, M.
and
Cerisoli, M.
1992.
Heatstroke and hyperthermias.
The Italian Journal of Neurological Sciences,
Vol. 13,
Issue. 4,
p.
337.
Ebadi, M.
Pfeiffer, R. F.
and
Murrin, L. C.
1992.
Current Aspects of the Neurosciences.
p.
159.
1994.
Malignant catatonia.
The Journal of Neuropsychiatry and Clinical Neurosciences,
Vol. 6,
Issue. 1,
p.
1.
1995.
Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy?.
The Journal of Neuropsychiatry and Clinical Neurosciences,
Vol. 7,
Issue. 2,
p.
135.
Langan Martin, Julie
and
Martin, Daniel J.
2016.
Life-Threatening Effects of Antipsychotic Drugs.
p.
223.
Caroff, Stanley N.
2020.
Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors.
Clinical Psychopharmacology and Neuroscience,
Vol. 18,
Issue. 2,
p.
322.
eLetters
No eLetters have been published for this article.